Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Water-Jet tool zaps tennis elbow pain in small trial

NCT ID NCT03487250

Symptom relief Sponsor: HydroCision, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new, less invasive surgery for tennis elbow. 29 adults with chronic elbow pain received a water-jet procedure guided by ultrasound. Researchers measured pain and function changes over 12 months to see if the treatment helped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

29 people

The number who actually took part.

Started

Aug 2016

Finished

Apr 2019

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with chronic, refractory lateral or medial elbow pain secondary to elbow tendinosis

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient is \> 18 years of age * Chronic lateral or medial elbow pain \> 3 month duration * History and clinical examination consistent with lateral or medial epicondylitis * Sonographic evidence of medial or lateral elbow tendinosis as evidenced by * tendon thickening and hypoechogenicity, * with or without hypervascularity on Doppler examination and, * with or without cortical irregularities, Or MRI findings consistent with lateral or medial tendinosis, with or without intrasubstance tear. * \> 3 months of non-operative treatment that included * nonsteroidal anti-inflammatory drugs * activity modification * physical therapy * elbow straps * With or without previous steroid injections, protein rich plasma injections, or stem cell injections * Patient is willing and able to provide informed consent and comply with the study protocol Exclusion Criteria: * Documented ipsilateral upper extremity musculoskeletal condition (other than elbow tendinosis in the same arm on the opposite side) * Bleeding disorders and/or current use of anti-coagulants with the inability to withhold anticoagulants for required time prior to procedure * Use of acetylsalicylic acid (ASA) and/or non-steroidal anti-inflammatory drug (NSAID) within 7 days of treatment * Steroid injection within 4 weeks of the study procedure * Active local or systemic infection * Patient found to have further degenerative changes of the elbow contributing to pain, such as cartilage thinning, loose body, or evidence of tendinosis other than medial or lateral, including triceps or ulnar collateral ligament. * Patient is known or suspected to be pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Elbow tendinosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

epicondylitis tendinosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Elbow, tennis

Contacts and locations

Locations

  • Noble Pain Management & Sports Medicine

    Fort Worth, Texas, 76110, United States

  • Orthopaedic Associates of Muskegon

    Muskegon, Michigan, 49444, United States

  • Penn Highlands

    DuBois, Pennsylvania, 15801, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.